Gene: RGS11
Official Full Name: regulator of G protein signaling 11provided by HGNC
Gene Summary: The protein encoded by this gene belongs to the RGS (regulator of G protein signaling) family. Members of the RGS family act as GTPase-activating proteins on the alpha subunits of heterotrimeric, signal-transducing G proteins. This protein inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits, thereby driving them into their inactive GDP-bound form. Alternative splicing occurs at this locus and four transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Nov 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33859 | RGS11 Knockout cell line (HeLa) | Human | RGS11 | 1:3~1:6 | Negative | Online Inquiry |
KO33860 | RGS11 Knockout cell line (A549) | Human | RGS11 | 1:3~1:4 | Negative | Online Inquiry |
RGS11 Gene Knockout Cell Lines are genetically engineered cell lines that have been specifically designed to lack the expression of the RGS11 gene, which encodes a protein that plays a crucial role in neuronal signaling pathways, particularly in regulating G-protein-coupled receptor (GPCR) activity. The knockout of RGS11 enables researchers to elucidate its precise function in cellular signaling, contributing to a deeper understanding of various physiological and pathological processes.
These cell lines function by utilizing CRISPR-Cas9 technology, which allows for precise and efficient editing of the genome. By excising the RGS11 gene, researchers can study the downstream effects on GPCR signaling, cellular proliferation, and differentiation pathways, providing insights into conditions such as neurodegenerative diseases, cardiovascular disorders, and certain cancers. The ability to manipulate these pathways opens new avenues for therapeutic interventions and development of novel drugs targeting GPCRs.
The scientific importance of RGS11 Gene Knockout Cell Lines is underscored by their applications in both basic and translational research. They are invaluable for investigating the mechanisms underlying signal transduction in health and disease, as well as for screening potential drug candidates that may modulate GPCR activity. Their use can lead to the identification of biomarkers and novel therapeutic targets, advancing the field of personalized medicine.
Unlike traditional cell lines, RGS11 knockout models offer researchers a unique advantage by providing a more accurate representation of the pathophysiological conditions associated with RGS11 dysregulation. This specificity enhances experimental reproducibility and allows for better assessment of drug efficacy and safety profiles compared to alternative models that may harbor confounding genetic variables.
In sum, RGS11 Gene Knockout Cell Lines are a powerful tool for researchers and clinicians seeking to advance our understanding of GPCR signaling and its implications in various diseases. By choosing our product, users will benefit from our company's expertise in genetic engineering and commitment to providing high-quality, reliable biological products that support pioneering research efforts.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.